ATE554097T1 - Verfahren zur herstellung von antithrombin-iii- zusammensetzungen - Google Patents

Verfahren zur herstellung von antithrombin-iii- zusammensetzungen

Info

Publication number: ATE554097T1
Authority: AT; Austria
Prior art keywords: antithrombin iii; producing; iii compositions; sugar chains; producing antithrombin
Prior art date: 2003-10-09

Application number

AT04773775T

Other languages

English (en)

Inventor

Tsuyoshi Yamada

Mitsuo Satoh

Yutaka Kanda

Kazuya Yamano

Original Assignee

Kyowa Hakko Kirin Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-09

Filing date

2004-10-08

Publication date

2012-05-15

2004-10-08 Application filed by Kyowa Hakko Kirin Co Ltd filed Critical Kyowa Hakko Kirin Co Ltd

2012-05-15 Application granted granted Critical

2012-05-15 Publication of ATE554097T1 publication Critical patent/ATE554097T1/de

Links

102000004411 Antithrombin III Human genes 0.000 title abstract 3
108090000935 Antithrombin III Proteins 0.000 title abstract 3
229960005348 antithrombin iii Drugs 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title 1
229930182474 N-glycoside Natural products 0.000 abstract 2
SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 abstract 1
PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 abstract 1
SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 abstract 1
OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract 1
OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 abstract 1
MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 abstract 1
229950006780 n-acetylglucosamine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8128—Antithrombin III
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01068—Glycoprotein 6-alpha-L-fucosyltransferase (2.4.1.68), i.e. FUT8
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/01—Hydro-lyases (4.2.1)
- C12Y402/01047—GDP-mannose 4,6-dehydratase (4.2.1.47), i.e. GMD
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y501/00—Racemaces and epimerases (5.1)
- C12Y501/03—Racemaces and epimerases (5.1) acting on carbohydrates and derivatives (5.1.3)
- C12Y501/03018—GDP-mannose 3,5-epimerase (5.1.3.18)

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Toxicology (AREA)
Peptides Or Proteins (AREA)
Enzymes And Modification Thereof (AREA)

AT04773775T 2003-10-09 2004-10-08 Verfahren zur herstellung von antithrombin-iii- zusammensetzungen ATE554097T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2003350164		2003-10-09
PCT/JP2004/015324 WO2005035563A1 (ja)	2003-10-09	2004-10-08	アンチトロンビンⅲ組成物の製造方法

Publications (1)

Publication Number	Publication Date
ATE554097T1 true ATE554097T1 (de)	2012-05-15

Family

ID=34431032

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04773775T ATE554097T1 (de)	2003-10-09	2004-10-08	Verfahren zur herstellung von antithrombin-iii- zusammensetzungen

Country Status (9)

Country	Link
EP (1)	EP1676860B1 (de)
JP (1)	JP4263191B2 (de)
KR (1)	KR101017336B1 (de)
CN (2)	CN103993056A (de)
AT (1)	ATE554097T1 (de)
AU (1)	AU2004279741B2 (de)
CA (1)	CA2542035C (de)
ES (1)	ES2383371T3 (de)
WO (1)	WO2005035563A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007099988A1 (ja) *	2006-02-28	2007-09-07	Kyowa Hakko Kogyo Co., Ltd.	α-1,6-フコシルトランスフェラーゼ変異体とその用途
SG175602A1 (en)	2006-07-05	2011-11-28	Catalyst Biosciences Inc	Protease screening methods and proteases identified thereby
CA2791144C (en) *	2006-07-05	2019-04-09	Catalyst Biosciences, Inc.	Protease screening methods and proteases identified thereby
EP2171052B1 (de)	2007-07-12	2014-08-27	Sangamo BioSciences, Inc.	Verfahren und zusammensetzung zur deaktivierung der alpha-1,6-fucosyltransferase-genexpression
EP2311864A4 (de)	2008-08-13	2013-07-31	Kyowa Hakko Kirin Co Ltd	Rekombinante protein-s-zusammensetzung
WO2013002330A1 (ja) *	2011-06-29	2013-01-03	協和発酵キリン株式会社	たん白質の精製方法
US9127274B2 (en) *	2012-04-26	2015-09-08	Alnylam Pharmaceuticals, Inc.	Serpinc1 iRNA compositions and methods of use thereof
ES2731595T3 (es)	2012-12-28	2019-11-18	Seikagaku Kogyo Co Ltd	Agente de pre-tratamiento y método de pre-tratamiento para antitrombina III que se va a someter a una prueba de Limulus
DK3218490T3 (en)	2014-11-15	2019-02-18	Zumutor Biologics Inc	DNA BINDING DOMAIN OF CRISPR SYSTEM FOR PRODUCING NON-FUCOSYLED AND PARTICULAR FUCOSYLED PROTEINS
EP3278814B1 (de) *	2015-03-31	2021-08-18	Kyowa Kirin Co., Ltd.	Therapeutische zusammensetzung mit antithrombin gamma
AU2020222120A1 (en)	2019-02-11	2021-09-02	Kyowa Kirin Co., Ltd.	Method for treating pregancy-induced hypertension nephrosis
CN111109248A (zh) *	2019-12-24	2020-05-08	武汉博士德生物工程有限公司	一种杂交瘤细胞冻存液及96孔板冻存复苏方法
CN115247160B (zh) *	2022-07-28	2024-03-15	格进(杭州)生物技术有限责任公司	蛋白核心岩藻糖基化修饰的检测方法
CN117567597B (zh) *	2024-01-17	2024-03-22	成都艾科斯伦医疗科技有限公司	一种抗凝血酶Ⅲ及抗Xa活性检测试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5843705A (en)	1995-02-21	1998-12-01	Genzyme Transgenic Corporation	Transgenically produced antithrombin III
US6054304A (en) *	1996-01-24	2000-04-25	Toyo Boseki Kabushiki Kaisha	α1-6 fucosyltransferase
AU2001271021A1 (en)	2000-07-05	2002-01-14	Japan As Represented By Secretary Of Osaka University	Process for producing glycoprotein
CA2953239A1 (en) *	2000-10-06	2002-04-18	Kyowa Hakko Kirin Co., Ltd.	Antibody composition-producing cell
EP1498490A4 (de) *	2002-04-09	2006-11-29	Kyowa Hakko Kogyo Kk	Verfahren zur herstellung einer antikörperzusammensetzung
BR0309145A (pt) *	2002-04-09	2005-02-01	Kyowa Hakko Kogyo Kk	Células das quais o genoma é modificado
JP2005058111A (ja) *	2003-08-14	2005-03-10	Univ Osaka	糖鎖修飾制御方法

2004
- 2004-10-08 ES ES04773775T patent/ES2383371T3/es not_active Expired - Lifetime
- 2004-10-08 JP JP2005514674A patent/JP4263191B2/ja not_active Expired - Lifetime
- 2004-10-08 AU AU2004279741A patent/AU2004279741B2/en not_active Expired
- 2004-10-08 CN CN201410016193.XA patent/CN103993056A/zh active Pending
- 2004-10-08 CA CA2542035A patent/CA2542035C/en not_active Expired - Lifetime
- 2004-10-08 CN CN200480035813.9A patent/CN1890262B/zh not_active Expired - Lifetime
- 2004-10-08 AT AT04773775T patent/ATE554097T1/de active
- 2004-10-08 EP EP04773775A patent/EP1676860B1/de not_active Expired - Lifetime
- 2004-10-08 KR KR1020067008648A patent/KR101017336B1/ko not_active Expired - Lifetime
- 2004-10-08 WO PCT/JP2004/015324 patent/WO2005035563A1/ja not_active Ceased

Also Published As

Publication number	Publication date
CA2542035A1 (en)	2005-04-21
ES2383371T3 (es)	2012-06-20
EP1676860B1 (de)	2012-04-18
CN1890262B (zh)	2015-01-28
KR20060125732A (ko)	2006-12-06
WO2005035563A1 (ja)	2005-04-21
AU2004279741B2 (en)	2010-03-11
JPWO2005035563A1 (ja)	2007-11-22
CA2542035C (en)	2013-02-26
EP1676860A1 (de)	2006-07-05
ES2383371T9 (es)	2012-12-14
CN103993056A (zh)	2014-08-20
HK1091500A1 (en)	2007-01-19
JP4263191B2 (ja)	2009-05-13
KR101017336B1 (ko)	2011-02-28
AU2004279741A1 (en)	2005-04-21
EP1676860A4 (de)	2008-12-31
CN1890262A (zh)	2007-01-03

Publication	Publication Date	Title
ATE554097T1 (de)	2012-05-15	Verfahren zur herstellung von antithrombin-iii- zusammensetzungen
ATE448231T1 (de)	2009-11-15	Verfahren zur herstellung von morphinan-6-on- produkten mit geringen konzentrationen von alpha-,beta-ungesättigten ketonverbindungen
DE60141706D1 (de)	2010-05-12	Verbindungen mit fungizider wirkung und verfahren zur ihrer herstellung und verwendung
ATE506356T1 (de)	2011-05-15	Verfahren zur herstellung von 3-halo-4,5-dihydro- 1h-pyrazolen
DE60031599D1 (de)	2006-12-14	Tintenstrahl-Harzzusammensetzung für Farbfilter, Verfahren zur Herstellung von Farbfiltern
ATE435231T1 (de)	2009-07-15	Verfahren zur herstellung verzweigterribonukleoside aus 1,2- anhydroribofuranose-zwischenprodukten
DE60316688D1 (de)	2007-11-15	Dehydrophenylahistine und analoge davon sowie ein verfahren zur herstellung von dehydrophenylahistinen und analogen davon
DE60308281D1 (de)	2006-10-26	Verfahren zur Herstellung von elektrolysiertem Wasser
ATE493425T1 (de)	2011-01-15	Verfahren zur herstellung ortho-metallierter metallverbindungen
ATE453648T1 (de)	2010-01-15	Verfahren zur herstellung von hexahydrofuroc2,3- büfuran-3-ol
DE102004035617B8 (de)	2018-09-20	Verfahren zur Herstellung von Substraten für Fotomaskenrohlinge
MY142821A (en)	2011-01-14	Polyvinylammonium compound, method of manufacturing same, acidic solution containing said compound and method of electrolytically depositing a copper deposit
ATE506351T1 (de)	2011-05-15	Verfahren zur herstellung von 10,11-dihydro-10- oxo-5h-dibenzoäb,füazepin-5-carboxamid
ATE376997T1 (de)	2007-11-15	Verfahren zur herstellung von 1,4- diphenylazetidinon-derivaten
DE502005000378D1 (de)	2007-03-29	Verfahren zur Herstellung von Mercaptoorganyl (alkoxysilan)
DE502005000428D1 (de)	2007-04-19	Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen
DE602005020185D1 (de)	2010-05-06	Verfahren zur herstellung von 17-hydroxy-6 beta, 7 beta, 15 beta,16 beta-bismethylen-17alpha-pregn-4henprodukte für dieses verfahren
ATE275149T1 (de)	2004-09-15	Verfahren zur herstellung von taxanderivaten
DE502005007702D1 (de)	2009-08-27	Verfahren zur herstellung von terrylen-3,4:11,12-t
DE60317413D1 (de)	2007-12-27	Verfahren zur Herstellung von Perfluorpolyethern mit Acylfluor-Endgruppen durch Reduktion von peroxidischen Perfluoropolyethern
ATE355200T1 (de)	2006-03-15	Verfahren zur herstellung einer tür eines kraftfahrzeugs sowie eine nach diesem verfahren hergestellte tür
ATE341558T1 (de)	2006-10-15	Verfahren zur herstellung von topiramate
DE50103009D1 (de)	2004-09-02	Verfahren zur herstellung von 2-alkyl-3-chlorphenolen
ATE396166T1 (de)	2008-06-15	Verfahren zur herstellung von 2,3-cis- substituierten 2-arylpropenalen
ATE501104T1 (de)	2011-03-15	Verfahren zur herstellung von 1,2,2,2-tetrafluor- ethyl-difluor-methylether